In one paragraphArticle in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
10 authors.
Zhenwei Zhang *State Key Laboratory of Biotherapy and Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu, China.ORCID 0000-0003-2906-9346 Vinay Kumar *Emeritus Group Cellular Biochemistry, Max-Planck-Institute for Multidisciplinary Sciences, Göttingen, Germany.ORCID 0000-0001-6642-8876 Sumeru PantaDepartment of Structural Dynamics, Max-Planck-Institute for Multidisciplinary Sciences, Göttingen, Germany.
Jiayun ZhongState Key Laboratory of Biotherapy and Department of Rheumatology and Immunology, West China Hospital, Sichuan University, Chengdu, China.
Olexandr DybkovBioanalytical Mass Spectrometry, Max-Planck-Institute for Multidisciplinary Sciences, Göttingen, Germany.ORCID 0000-0001-6005-7242 Haohao DongState Key Laboratory of Biotherapy and National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, China.ORCID 0000-0002-5022-3494 Berthold KastnerEmeritus Group Cellular Biochemistry, Max-Planck-Institute for Multidisciplinary Sciences, Göttingen, Germany.ORCID 0000-0002-6051-0198 Henning UrlaubBioanalytical Mass Spectrometry, Max-Planck-Institute for Multidisciplinary Sciences, Göttingen, Germany.ORCID 0000-0003-1837-5233 Holger StarkDepartment of Structural Dynamics, Max-Planck-Institute for Multidisciplinary Sciences, Göttingen, Germany. hstark1@gwdg.de.
Reinhard LührmannEmeritus Group Cellular Biochemistry, Max-Planck-Institute for Multidisciplinary Sciences, Göttingen, Germany. reinhard.luehrmann@mpinat.mpg.de.ORCID 0000-0003-3253-7518 Funding
Deutsche Forschungsgemeinschaft (German Research Foundation) SFB1565Deutsche Forschungsgemeinschaft (German Research Foundation) SFB1565, project number 469281184National Natural Science Foundation of China (National Science Foundation of China) NSFC 32300442Sichuan University (SCU) YJ202344
6 · The paper itselfAbstract
Formation of the activated human spliceosome (B
Indexed as
Cyclin-Dependent KinasesDEAD-box RNA HelicasesRNA HelicasesRNA Splicing FactorsSpliceosomesCryoelectron MicroscopyHumansPhosphoproteinsPhosphorylationRibonucleoprotein, U2 Small NuclearRNA SplicingCyclin-Dependent KinasesDEAD-box RNA HelicasesPhosphoproteinsRibonucleoprotein, U2 Small NuclearRNA HelicasesRNA Splicing FactorsSF3B1 protein, human
Identifiers
PMID42399621
PMCPMC13332222
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390